From class waivers to precision medicine in paediatric oncology-Reference-Cited by-同舟云学术

From class waivers to precision medicine in paediatric oncology

Published:2017-07 Issue:7 Volume:18 Page:e394-e404
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Pearson Andrew D J,Pfister Stefan M,Baruchel Andre,Bourquin Jean-Pierre,Casanova Michela,Chesler Louis,Doz François,Eggert Angelika,Geoerger Birgit,Jones David T W,Kearns Pamela R,Molenaar Jan J,Morland Bruce,Schleiermacher Gudrun,Schulte Johannes H,Vormoor Josef,Marshall Lynley V,Zwaan C Michel,Vassal Gilles

Publisher

Elsevier BV

Subject

Oncology

Reference18 articles.

1. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries;Pritchard-Jones;Lancet Oncol,2013

2. Survival of European children and young adults with cancer diagnosed 1995–2002;Gatta;Eur J Cancer,2009

3. Long-term follow-up of people who have survived cancer during childhood;Skinner;Lancet Oncol,2006

4. Long-term cause-specific mortality among survivors of childhood cancer;Reulen;JAMA,2010

5. Inhibition of mutated, activated BRAF in metastatic melanoma;Flaherty;N Engl J Med,2010

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delays in Pediatric Evaluation of New and Relevant Cancer Therapies;The Journal of Pediatrics;2024-02

2. Future of Clinical Trials and Application of Precision Medicine;Pediatric Oncology;2024

3. Collaborative Innovations in Childhood Cancer Therapies;Handbook of Experimental Pharmacology;2024

4. Policy of pediatric oncology drug development;Essentials of Translational Pediatric Drug Development;2024

5. Clinical research with targeted drugs in paediatric oncology;Drug Discovery Today;2023-08